B-type natriuretic peptide predicts new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention

Peptides

Volumn 35, Issue 1, 2012, Pages 74-77

  Asanin, Milika ^a   Stankovic, Sanja ^b   Mrdovic, Igor ^a   Matic, Dragan ^a   Savic, Lidija ^a   Majkic Singh, Nada ^b   Ostojic, Miodrag ^a   Vasiljevic, Zorana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Atrial fibrillation; B type natriuretic peptide; Primary percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; TROPONIN I;

ADULT; ARTICLE; CARDIAC PATIENT; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN;

AGED; ANGIOPLASTY; AREA UNDER CURVE; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; ROC CURVE; STATISTICS, NONPARAMETRIC;

EID: 84859796046     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.02.022     Document Type: Article

References (20)

1. Aronson D, Boulos M, Suleiman A, Bidoosi S, Agmon Y, Kapeliovich M, et al. Relation of C-reactive protein and new onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol 2007;100:753-7. (Pubitemid 47268263)
2. Aronson D. Clinical significance of atrial fibrillation after myocardial infarction. Expert Rev Cardiovasc Ther 2011;9:1111-3.
3. Asanin M, Perunicic J, Mrdovic I, Matic M, Vujisic-Tesic B, Arandjelovic A, et al. Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction. Eur J Heart Fail 2005;7:671-6. (Pubitemid 40733002)
4. Crenshaw BS, Ward SR, Granger CB, Stebbins AL, Topol EJ, Califf RM. Atrial fibrillation in the setting of acute myocardial infarction: the GUSTO-I experience global utilization of streptokinase and TPA for occluded coronary arteries. J Am Coll Cardiol 1997;30:406-13. (Pubitemid 27339320)
5. Crilley JG, Farrer M. Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction. Heart 2001;86:638-42. (Pubitemid 33086878)
6. Hod H, Lew AS, Keltai M, Cercek B, Geft IL, Shah PK, et al. Early atrial fibrillation during evolving myocardial infarction: a consequence of impaired left atrial perfusion. Circulation 1987;75:146-50. (Pubitemid 17234552)
7. Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, et al. B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure. J Am Coll Cardiol 2006;47:742-8. (Pubitemid 43243094)
8. Kinjo K, Sato H, Sato H, Ohnishi Y, Hishida E, Nakatani D, et al. Osaka Acute Coronary Insufficiency Study (OACIS) Group Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol 2003;92:1150-4. (Pubitemid 37377822)
9. Køber L, Swedberg K, McMurray JJ, Pfeffer MA, Velazquez EJ, Diaz R, et al. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail 2006;8:591-8. (Pubitemid 44604352)
10. Lehto M, Snapinn S, Dickstein K, Swedberg K, Nieminen MS. OPTIMAAL investigators prognostic risk of atrial fibrillation in acute myocardial infarction complicated by left ventricular dysfunction: the OPTIMAAL experience. Eur Heart J 2005;26:350-6. (Pubitemid 40287380)
11. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91. (Pubitemid 23195436)
12. Nielsen FE, Andersen HH, Gram-Hansen P, Sørensen HT, Klausen IC. The relationship between ECG signs of atrial infarction and the development of supraventricular arrhythmias in patients with acute myocardial infarction. Am Heart J 1992;123:69-72.
13. Parashar S, Langberg JJ, Vaccarino V, Reid KJ, Spertus J, Lloyd MS. Elevated BNP predicts new onset atrial fibrillation complicating acute myocardial infarction: analysis of the TRIUMPH registry. J Am Coll Cardiol 2010;55(A7):E61.
14. Pedersen OD, Bagger H, Køber L, Torp-Pedersen C. The occurrence and prognostic significance of atrial fibrillation/-flutter following acute myocardial infarction. TRACE Study group. TRAndolapril Cardiac Evalution. Eur Heart J 1999;20:748-54. (Pubitemid 29209908)
15. Rathore SS, Berger AK, Weinfurt KP, Schulman KA, Oetgen WJ, Gersh BJ, et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 2000;101:969-74. (Pubitemid 30131697)
16. Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation 1997;96:1686-95. (Pubitemid 27375370)
17. Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J 2009;30:1038-45.
18. Solti F, Vecsey T, Kekesi V, Juhasz-Nagy A. The effect of atrial dilatation on the genesis of atrial arrhythmias. Cardiovasc Res 1989;23:882-6. (Pubitemid 19269865)
19. Waldecker B. Atrial fibrillation in myocardial infarction complicated by heart failure: cause or consequence? Eur Heart J 1999;20:710-2. (Pubitemid 29209903)
20. Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, et al. New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience. Am Heart J 2000;140:878-85.